FDA Panel Recommends New Postmarket Requirements for Breast Implants
Posts published in “Breast Implants”
2019 Meeting Materials of the General and Plastic Surgery Devices Panel
FDA Panel: Too early to pull textured breast implants over cancer risk, need more data
Rare immune-system cancer linked for first time to buttock implant
Interesting discussion on this important topic – Summary International Expert Meeting on breast implant-associated lymphoma
Topics to be discussed: breast implant associated anaplastic large cell lymphoma (BIA-ALCL); systemic symptoms reported in patients receiving breast implants; the use of registries for…
Commission reply to a Petition “For a Compensation Fund for PIP Breast Implants and CE” from the website change.org
After loosing the CE Mark and the ANSM recall – MHRA statement on Allergan